- Home
- CAH vs DXCM Comparison
CAH vs DXCM Comparison
Compare CAH & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAH
- DXCM
- Stock Information
- Founded
- CAH 1979
- DXCM 1999
- Country
- CAH United States
- DXCM United States
- Employees
- CAH N/A
- DXCM N/A
- Industry
- CAH Other Pharmaceuticals
- DXCM Medical/Dental Instruments
- Sector
- CAH Health Care
- DXCM Health Care
- Exchange
- CAH Nasdaq
- DXCM Nasdaq
- Market Cap
- CAH 37.6B
- DXCM 31.7B
- IPO Year
- CAH N/A
- DXCM 2005
- Fundamental
- Price
- CAH $150.06
- DXCM $75.78
- Analyst Decision
- CAH Buy
- DXCM Strong Buy
- Analyst Count
- CAH 15
- DXCM 19
- Target Price
- CAH $159.00
- DXCM $99.89
- AVG Volume (30 Days)
- CAH 2.1M
- DXCM 4.7M
- Earning Date
- CAH 10-31-2025
- DXCM 10-23-2025
- Dividend Yield
- CAH 1.36%
- DXCM N/A
- EPS Growth
- CAH 86.96
- DXCM N/A
- EPS
- CAH 6.45
- DXCM 1.43
- Revenue
- CAH $222,578,000,000.00
- DXCM $4,300,800,000.00
- Revenue This Year
- CAH $12.83
- DXCM $17.03
- Revenue Next Year
- CAH $7.90
- DXCM $15.59
- P/E Ratio
- CAH $23.22
- DXCM $53.04
- Revenue Growth
- CAH N/A
- DXCM 9.30
- 52 Week Low
- CAH $106.54
- DXCM $57.52
- 52 Week High
- CAH $168.44
- DXCM $93.25
- Technical
- Relative Strength Index (RSI)
- CAH 47.69
- DXCM 42.30
- Support Level
- CAH $147.48
- DXCM $75.39
- Resistance Level
- CAH $153.89
- DXCM $77.84
- Average True Range (ATR)
- CAH 2.66
- DXCM 2.51
- MACD
- CAH 0.25
- DXCM -0.00
- Stochastic Oscillator
- CAH 50.07
- DXCM 40.45
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.